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Abstract 
 
 Many organisms around the world including plants, marine organisms, and microbes release 
chemicals used for things such as pigment or defense against other organisms. These chemicals are 
known as secondary metabolites and have been found to exhibit promising activity against many 
infectious diseases and cancer. Natural products chemistry is the study of these secondary 
metabolites with one of the purposes to discover new small organic molecules for potential 
pharmaceutical use in the future.  With parasitic diseases, such as malaria, prominent throughout the 
poorest regions of the world, there are great opportunities for discovering anti-malarial drugs from 
natural products. Approximately 250 million new malaria cases are discovered each year, and of 
these cases one to three million will not survive the disease. Anti-malarial drugs, such as chloroquine 
and quinine, have decreasing effectiveness, because the parasites have already formed strong 
resistance. For this reason, new pharmaceutical drugs are needed to combat this growing global 
catastrophe. This project focuses on finding new anti-malarial drugs from secondary metabolites 
produced by endophytic fungi and bacteria. Approximately, 900 filamentous fungi and bacteria have 
been isolated from Florida mangroves for this study. Their compounds were extracted in methanol 
and sent off for bioassay against Plasmodium falciparum. The active and partially active compounds 
were then scaled up and fractionated via Medium and High Pressure Liquid Chromatography and 
re-submitted for bioassay. Active fractions were studied with Nuclear Magnetic Resonance 
Spectroscopy. 
 
 
I. Introduction 
 
 Malaria is a vector borne disease caused by Plasmodium parasites, with Plasmodium falciparum 
being the most infectious. Being a vector borne illness, pharmaceuticals for human ingestion in 
conjunction with mosquito pesticides must be used in order to obliterate the virus completely. 
Malaria primarily affects poor populations in tropical and subtropical areas, where the temperature 
and rainfall are most suitable for the development of the malaria-causing Plasmodium parasites in 
Anopheles mosquitoes (Greenwood et al. 2008). Malaria has not had the same disastrous effects on 
highly developed nations due to the financial capabilities of those governments, therefore making it 
possible to fund large anti-malarial operations. With funding at a minimal, malaria plays a major role 
in the fatality rates of developing nations. Childhood deaths in Africa due to malaria climbed 
relentlessly as chloroquine-resistant Plasmodium parasites spread across the continent (Greenwood et 
al. 2008). With resistance occurring more rapidly, an opening has formed for those capable to 
develop new anti-malarial drugs to replace the current and ineffective pharmaceuticals. When there 
is more diversity between the anti-malarial drugs, there is less of a chance for resistance to develop, 
therefore the more compounds capable of killing the parasite, the better the results. 
 The major force behind pharmaceuticals today is the development of synthetic derivatives to 
the already established cures. Penicillin is a classic example of utilizing the compound’s skeleton to 
create similar synthetic derivatives to fight the bacterial cell walls. After many attempts have been 
made with resistance showing up faster with each derivative or combination treatment created, other 
sources must be found in order to decrease the chance of resistance in bacteria, parasites, and the 
like (Greenwood et al. 2008). Malaria is already showing signs of rapid resistance to new drugs, 
therefore more diversity is necessary to help those is dire need of a cure (Greenwood et al. 2008). 
Natural products chemistry presents an alternative route to discovering new classes of compounds 
to endure greater diversity between drugs. Instead of just modifying compounds discovered from 
nature, natural products chemistry searches for completely new small molecules being produced 
naturally all over the world. Pharmaceuticals around the world have been derived from natural 
products, and without these original discoveries, their synthetic counterparts might not exist today 
(Baker 2007). Examples of these naturally occurring ailments are penicillin, aspirin, taxol, and 
artemisinin. Artemisinin in particular is a molecule discovered to treat malaria, and it was found in 
the plant Artemisia annua, a plant commonly used in Chinese Medicine practices (Vroman et al, 1999). 
Although artemisinin was an effective antimalarial drug temporarily, drug combinations with an 
artemisinin derivative and anti-vector measures are already underway around the world as the global 
community recognizes the need for more effective interventions (Greenwood et al. 2008). It is 
obvious that derivatives are not enough as resistance continues to prevail, and although three of the 
fore said pharmaceuticals were isolated from trees and plants, there is always the possibility that the 
compounds they are producing are the direct result of a symbiosis with microorganisms. Regardless 
of the producer, these are all examples of organisms producing chemicals that are not directly related 
to their primary metabolic processes. Rather, they are dubbed secondary metabolites, and can be 
used for chemical defense against predation, chemical signaling, pigmentation, and anti-fouling or 
other surface phenomena (McClintock & Baker, 2001). Especially in the case of an organism fearing 
predation, it can produce these secondary metabolites to deter being devoured by the predator. They 
can produce compounds that are toxic to their predators as well as produce the exotic pigmentations 
to forewarn them of these toxic secondary metabolites. For marine life in particular, overgrowth of 
biofouling organisms can have fatal consequences; therefore anti-fouling compounds are extremely 
useful secondary metabolites to produce and many organisms have done just that.  
Since marine and coastal environments have added reasons to produce secondary 
metabolites, while also being greatly diversified, they are great candidates for drug discovery and 
chemical ecology. Mangroves inhabit both marine and terrestrial ecosystems, therefore one might 
assume they would produce outstanding natural products on their own, such as the mangrove  
Avicennia marin (white mangrove), which has been used in Chinese Medicine for the treatment of 
diabetes (Li et al 2004). Although macroorganisms have been found to be very chemically defended, 
as stated above, there are sometimes other organisms deserving recognition for their relationship to 
these macroorganisms (McClintock & Baker 2001). As alluded to before when speaking of penicillin, 
artemisinin, etc., there is the possibility of microorganisms producing these potent secondary 
metabolites. Many of the coastal plants or marine algae have been found to contain microorganisms 
living in symbiosis with their plant or algal host. These organisms [endophytes] reside in the living 
tissues of the host plant and do so in a variety of relationships, ranging from symbiotic to slightly 
pathogenic (Strobel & Daisy, 2003). These endophytes can be defined as microorganisms colonizing 
healthy plant tissue without causing overt symptoms in or apparent injury to the host (Li et al 2004).  
The endophytes living within the mangrove habitat have proved to be a rich source of new fungal 
species, and now form the second largest ecological sub-group of marine fungi (Li et al 2004). As 
predicted these mangrove endophytes contain a plethora of secondary metabolites of their own 
waiting to be discovered. Castillo et al recovered six novel bioactive streptomycetes from Notofagus 
spp. growing in Patagonian Chile. The isolates were characterized by molecular and morphological 
features and found to be active against such plant pathogens as Phytophthora cinnamomi and Pythium 
ultimum (2007). With mangrove endophytes as the target, the Florida coast was an obvious candidate 
for the growth of diverse microorganisms.  
  
 II. Method 
1. Collection 
 The greater the diversity of endophytes the better, therefore the mangrove samples taken 
were from different sections of branches and leaves of black, red, and white mangroves around 
Coquina Beach, Florida and the Everglades. Collections for Coquina Beach were done by walking 
through the mangrove patches and cutting off the desired 
sections of mangroves greater than 5 feet tall. In the everglades, 
Jeremy Beau and his undergraduates canoed around specific 
areas of the everglades with exceptional mangrove growth. Of 
the samples collected, each branch was cut into five sections 
and surface sterilized. All surface sterilization and microbial work was done in a BSL-2 biosafety 
cabinet with tools flame sterilized after an isopropanol rinse. The surface sterilization consisted of a 
thirty second soak in bleach, followed by water, then an isopropyl alcohol rinse, and a final water 
rinse. The pieces were then divided into equal parts of four pieces per type of autoclave sterilized 
media. The types of media used were sabouraud dextrose agar (SDA), SDA containing the antibiotic 
p-chloramphenicol, Actinomyces media (1 L seawater, 10 g starch, 4 g yeast extract, 2 g peptone, 15 
g/L SDA), potato dextrose agar, and “saw dust” agar, which was created from blended and freeze 
dried mangrove pieces. All of these different media help to produce the most diverse collection of 
bacterial and fungal endophytes. Actinomyces media was used to selectively culture those bacteria 
that are in the class actinobacteria. They look filamentous like fungi, however they have the 
properties of bacteria, therefore special media was used in the initial isolation to ensure actinomyces 
growth over other microbial endophytes. 
 
 2. Growth, Extraction, and Separation 
 As soon as growth was noticeable on the original cultures, individual isolates were precisely 
separated and placed on individual plates of SDA for fungi and trypticase soy agar (TSA) for 
bacteria. They were then incubated at 37oC for 18-21 days. If more than one isolate remained after 
the incubation time, those were further separated until only one isolate remained per petri dish of 
agar. In order to test these samples against Plasmodium falciparum, the sample size needed to be larger 
therefore increasing the concentration of the extract. Each individual bacterial or fungal isolate was 
scaled up into two larger plates of TSA or SDA, respectively and re-incubated for another 18-21 
days.  
 
 
 
 
The actinomyces samples were grown on actinomyces media for the first isolation step; however the 
following isolates were grown on TSA along with the other bacteria. All isolates were archived in 
test tubes with slants of their respective agar kept at 4oC and mycelia was placed in cryogenic vials 
with 20% Glycerol/Water kept at -80 oC. The incubated samples in petri dishes were then freeze 
dried and packed into 20 mL scintillation vials and extracted with methanol. Methanol was used 
because of its desirable broad range of polarity for extracting organic molecules. The methanol 
extract was then dried down and dissolved at 30mg/mL in dimethyl sulfoxide and submitted in 96 
well plates for bioassay. 
 
 
 All samples collected from Coquina Beach, Florida were chemically investigated in addition 
to screening via bioassay guided fractionation, however the Everglades, Florida endophytes were 
only partially submitted for screening against Malaria due to time constraints. Samples showing 
activity from Coquina Beach had to be scaled up larger than the two plate sizes used for the bioassay 
in order to be chemically investigated. Therefore, some of those endophytes that were scaled up, 
were regrown from their archive in a two liter flask containing one liter of agar for 18 days. After 
following the same extraction process described above, they were then fractionated using normal 
and reversed phase medium pressure liquid chromatography (MPLC) and high pressure liquid 
chromatography (HPLC). These separations were done on a CombiFlaskRf Teledyne ISCO MPLC 
and a Shimadzu HPLC. The solvent systems used for the MPLC separations were hexane to ethyl 
acetate to methanol for normal phase and water to methanol for reversed phase. Only reversed 
phase HPLC was used with a 30 minute gradient from 100% water to 100% acetonitrile as a solvent 
system. Active fractions were analyzed via a 400 MHz Varian nuclear magnetic resonance 
spectrometer (NMR). 
 
 
 
 
 
 
 
3. Bioassay 
All bioassays were done in Dr. Dennis Kyle’s lab with the University of South Florida’s 
College of Public Health. The transgenic P. falciparum clone 3D7 expressing luciferase was grown in 
continuous culture using the Trager and Jenson method (1978). Chloroquine, dihydroartemisinin 
and atovaquone were used as the control drugs added to each set of assay plates. Positive and 
negative controls were included in each microtiter plate. Drug-free parasitized erythrocytes were the 
positive controls, while parasitized erythrocytes dosed with a high concentration of chloroquine or 
dihydroartemisinin were the negative controls. Assay plates were processed using Luciferase Assay 
System reagents purchased from Promega, data analysis was performed using Dataspects, Inc, and 
the EC50 was calculated using a non-linear regression analysis. Bioassay results displayed both active 
and partially active extracts and their cytotoxicity. 
  
III. Results 
 
 Since the focus of this project was to find novel compounds to combat the Malarial causing 
vector Plasmodium falciparum, the microbial samples examined were all done via bioassay guided 
fractionation. Only the four fungal endophyte samples from the Coquina Beach collection were 
chemically investigated, whereas the Everglades samples only have bioassay results. The bioassay 
results for the Everglades microbes are shown in Table 1. The four samples shown in red have 
greater than 66% inhibition towards the parasite, and the remaining 10 samples in black show 33-
66% inhibition. Further investigation into the activity of these samples is needed. Of all Everglades 
samples cultured and tested to date, there were a total of 14 active and partially active compounds 
out of 259 fungal and bacterial endophytes. 
The samples from Coquina Beach resulted in four promising fungal isolates showing initial 
activity against Malaria out of 357 total isolates, as seen in Table 1. Of these four fungal endophytes, 
one continued to show greater than 66% inhibition at 5 and 50 µg/mL after the initial MPLC run. 
The other three samples all lost activity after the first separation, which could be due to synergistic 
effects between compounds or inconsistent bioassay results. A separation scheme can be seen in the 
flow chart of figure 1 showing all of the fractions collected and their respective masses. The initial 
MPLC separation of the fungal extract CQ10-20A-4 is shown in figure 2. The fractions eluted in 
approximately 100% ethyl acetate, D, E, and F as shown on the MPLC chromatogram for sample 
CQ10-20A-4, still exhibited greater than 66% inhibition at 5 and 50 µg/mL after the initial 
separation. These three fractions totaling 42 milligrams were combined and further separated using 
reversed phase HPLC. As seen in figure 3, there were 22 fractions separated from D, E, and F. 
Fractions 1-7 were not particularly UV active, so they were combined, while all other fractions were 
analyzed via proton NMR spectroscopy. All 22 fractions were resubmitted for bioassay. Fractions 8 
and 17 continue to show partial activity against the parasite, while fractions 13 and 14 still show 
greater than 50-90% inhibition at the IC50 values against Plasmodium falciparum. The 1H NMR spectra 
of these four fractions are shown in figures 4-7. Of these four fractions, 13 and 14 hold the 
cytotoxicity of the initial crude submitted, however there is greater than a tenfold difference between 
the IC50 values for the therapeutic index and cytotoxicity, meaning these fractions remain plausible 
cures for Malaria.  
In order to find what compound is responsible for this activity, further fractionation with 
HPLC must be done in conjunction with liquid chromatography-mass spectrometry (LC-MS) and 
carbon NMR. Although further detail is needed to identify the compound responsible for the 
promising anti-malarial activity in fractions 13 and 14, the 1H NMR spectrum in figures 6 and 7 give 
some insight into the proton interactions. For example, at about δH = 0.75-0.85 in figure 6 there is a 
characteristic doublet peak of an isopropyl hydrogen. There are also multiple peaks of amines and 
olefins in both figures 6 and 7 at δH = 3.5-5.5. 
 
 
 
 
 
 
 
IV. Tables and Figures 
 
Table 1 – Bioassay Results for both Collections: 
Coquina Beach Collection Everglades Collection 
CQ10-20A-4 EG10-46C-3 EG10-66E-3 
CQ10-36C-3 EG10-65C-3B EG10-66B-3 
CQ10-14C-1 EG10-65C-1 EG10-66C-4B 
CQ10-18A-1 EG10-52C-2 EG10-47C-1 
 EG10-30A-3 EG10-28B-4 
 EG10-33B-1 EG10-30C-1 
 EG10-33B-2 EG10-30D-3 
 
Figure 1 – Separation Flow Chart of Active Sample CQ10-20A-4 
 
CQ10-20A-4 NP MPLC (800 mg)
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G H
Figure 2 – CQ10-20A-4: Normal Phase MPLC Chromatogram 
 
 
 
 
 
 
 
 
 
 
Figure 3 – CQ10-20A-4-DEF: Reversed Phase HPLC Chromatogram 
 
D E F 
Figure 4 – CQ10-20A-4-DEF-8: 1H NMR Spectrum 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 – CQ10-20A-4-DEF-17: 1H NMR Spectrum  
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Figure 6 – CQ10-20A-4-DEF-13: 1H NMR Spectrum 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 – CQ10-20A-4-DEF-14: 1H NMR Spectrum 
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